Genetic Alteration

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Tabuk Pharmaceuticals
Tabuk PharmaceuticalsSaudi Arabia - Riyadh
1 program
Interferential therapyN/A1 trial
Active Trials
NCT07439874CompletedEst. Jan 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Tabuk PharmaceuticalsInterferential therapy

Clinical Trials (1)

NCT07439874Tabuk PharmaceuticalsInterferential therapy

Genetic Alterations From Physical Therapy in Low Back Pain and Disc Degeneration

Start: Aug 2024Est. completion: Jan 2026
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space